PPC vs. MED, K, GIS, TSN, MKC, HRL, SJM, CPB, CAG, and SFD
Should you be buying Pilgrim's Pride stock or one of its competitors? The main competitors of Pilgrim's Pride include Medifast (MED), Kellanova (K), General Mills (GIS), Tyson Foods (TSN), McCormick & Company, Incorporated (MKC), Hormel Foods (HRL), J. M. Smucker (SJM), Campbell's (CPB), Conagra Brands (CAG), and Smithfield Foods (SFD).
Pilgrim's Pride vs. Its Competitors
MEDIFAST (NYSE:MED) and Pilgrim's Pride (NASDAQ:PPC) are both consumer staples companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation.
MEDIFAST has a beta of 0.85, meaning that its share price is 15% less volatile than the S&P 500. Comparatively, Pilgrim's Pride has a beta of 0.45, meaning that its share price is 55% less volatile than the S&P 500.
In the previous week, Pilgrim's Pride had 10 more articles in the media than MEDIFAST. MarketBeat recorded 11 mentions for Pilgrim's Pride and 1 mentions for MEDIFAST. Pilgrim's Pride's average media sentiment score of 1.27 beat MEDIFAST's score of 0.00 indicating that Pilgrim's Pride is being referred to more favorably in the news media.
95.5% of MEDIFAST shares are owned by institutional investors. Comparatively, 16.6% of Pilgrim's Pride shares are owned by institutional investors. 2.9% of MEDIFAST shares are owned by company insiders. Comparatively, 82.6% of Pilgrim's Pride shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
MEDIFAST presently has a consensus target price of $16.50, indicating a potential upside of 32.50%. Pilgrim's Pride has a consensus target price of $47.67, indicating a potential upside of 26.74%. Given MEDIFAST's higher probable upside, analysts plainly believe MEDIFAST is more favorable than Pilgrim's Pride.
Pilgrim's Pride has higher revenue and earnings than MEDIFAST. Pilgrim's Pride is trading at a lower price-to-earnings ratio than MEDIFAST, indicating that it is currently the more affordable of the two stocks.
Pilgrim's Pride has a net margin of 6.81% compared to MEDIFAST's net margin of 0.76%. Pilgrim's Pride's return on equity of 37.15% beat MEDIFAST's return on equity.
Summary
Pilgrim's Pride beats MEDIFAST on 11 of the 15 factors compared between the two stocks.
Get Pilgrim's Pride News Delivered to You Automatically
Sign up to receive the latest news and ratings for PPC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding PPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Pilgrim's Pride Competitors List
Related Companies and Tools
This page (NASDAQ:PPC) was last updated on 10/23/2025 by MarketBeat.com Staff